Drug Development Challenges and Opportunities: Insights from the GLSA September 2024 Networking Event
Drug development challenges and opportunities continue to shape the pharma and biotech landscape. The Global Life Sciences Alliance (GLSA) September 2024 networking event brought together industry leaders to discuss clinical trials, innovation, and collaboration across the research ecosystem.
Below is a recap of the key discussions and insights shared during the session.
Opening Remarks on Drug Development Operations and Vendor Oversight
The meeting opened with remarks from Ryan Williamson. He shared insights from his background in biospecimen operations and vendor oversight.
His experience highlighted how strong vendor management directly impacts trial quality and timelines. The discussion set the stage for broader conversations on operational alignment and accountability.
Drug Development Challenges in Biotech and Pharma
Next, Chris Matheus discussed the role of smaller Contract Research Organizations (CROs). He emphasized their importance in managing data for large and complex trials.
Chris outlined common challenges these CROs face. These include limited resources, data complexity, and changing industry standards. The discussion reinforced the need for collaboration and efficient partnerships.
Networking and Collaboration as a Growth Opportunity
Throughout the event, Chris encouraged attendees to engage in breakout discussions. He also highlighted ongoing GLSA networking opportunities.
Information was shared on how to join future GLSA events and the Women of Life Sciences group. These initiatives continue to strengthen professional connections across the industry.
Addressing Current Challenges in Biotech and Pharma
The conversation then shifted to current challenges affecting biotech and pharma. Sara Tylosky of Farmacon Global joined Chris to discuss layoffs, financial pressure, inflation, and geopolitical uncertainty.
These factors have changed how companies plan and operate. Attendees shared strategies for staying flexible during uncertain times.
Michael Young added insights from the DPharm conference. He noted that development delays and industry adaptation were key themes. This sparked a broader discussion on resilience and innovation.
Spotlight on the Innovation Network Conference
Jeff Smith from Smith & Jones Innovation introduced the Innovation Network Conference. The event will take place October 3–4 in West Chester, Pennsylvania.
Jeff explained the value of curated breakout sessions and smaller group sizes. This format encourages deeper discussion and more actionable insights.
https://innovationgathering.network/
Looking Ahead: Upcoming Events and Opportunities
The session concluded with updates on upcoming industry events. These included the WCG MAGI Conference, where Michael Young will present on the FDA Diversity Action Plan.
These events offer continued learning and networking opportunities for professionals across clinical research.
Conclusion: Building Connections to Drive Future Success
Addressing drug development challenges and opportunities requires open dialogue, collaboration, and shared learning across the industry. The meeting wrapped up with informal conversation and shared travel stories. This lighthearted close reflected the collaborative spirit of GLSA events.
Despite ongoing challenges, the discussion highlighted many opportunities for growth and innovation. Strong connections and shared knowledge remain critical for future success.
Stay tuned for more insights from upcoming GLSA networking events. Reach out if you would like to participate in future discussions.
About GLSA
Global Life Sciences Alliance (GLSA) connects biotechs, pharma, CROs, and clinical research sites with the right experts, advisors, and solutions to accelerate development and reduce risk. With a network of more than 200 trusted partners spanning pre-clinical and clinical research, GLSA offers flexible, cost-effective access to specialized expertise and services that support early-stage biotechs, mid-size pharma, and global pharmaceutical companies.
When you need trusted, global resources to accelerate your research, GLSA helps you scale smarter and move you forward with confidence.
To learn how GLSA can support your organization, connect with Denise McNerney or Chris Matheus for a conversation about your goals and challenges.